Peptide dendrimers have shown promise as an attractive platform for drug delivery. In this
study, mPEGylated peptide dendrimer–doxorubicin (dendrimer–DOX) conjugate‐based …

Peptide dendrimer drug conjugate based nanoparticles are recently developed as a
potential candidate for drug delivery vehicle. In this study, we prepared and characterized …

Nanoparticles, such as dendritic polymers, are currently investigated as excellent
candidates for drug delivery vehicles. In this study, we report the preparation and …

Stimuli-responsive peptide dendrimer-drug conjugates have presented significant potential
for cancer therapy. To develop an effective nanoscale chemotherapeutic prodrug, we …

Background Since cancer cells are normally over-expressed cathepsin B, we synthesized
dendrimer-methoxy poly (ethylene glycol)(MPEG)-doxorubicin (DOX) conjugates using a …

Peptide dendrimer-based nanoparticles have presented significant potential as candidates
for drug delivery system. In this study, we synthesized and characterized enzyme-responsive …

Peptide nanodrugs have been developed as promising antitumor chemotherapeutics
because they partially overcome the drawbacks of free peptide drugs, but insufficient tumor …

Multidrug resistance (MDR) is a common phenomenon in clinical oncology and is a major
obstacle to cancer chemotherapy. Many nanoparticle (NP)-based drug delivery systems …

Because of the synergistic effects of drugs and minimal drug dose for cancer therapy,
combination chemotherapy is frequently used in the clinic. In this study, hyaluronic acid …

Abstract Development of multifunctional nanoscale drug-delivery systems for targeted
cancer therapy still remains a great challenge. Here, we report the synthesis of cyclic …